Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 7Genitourinary 7Gastrointestinal 7CNS 7Sarcoma 6Myeloid 6Gynecologic 1Dermatologic 1

Conditions

Ovarian Neoplasms 8Fallopian Tube Neoplasms 5Endometrial Neoplasms 5Uterine Cervical Neoplasms 4Melanoma 3Carcinoma, Hepatocellular 3Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Wilms Tumor 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Osteosarcoma 1Neuroblastoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 2Filgrastim 2sodium thiosulfate 1X-Rays 1Thiotepa 1Specimen Handling 1Restraint, Physical 1Psychiatric Rehabilitation 1Phantoms, Imaging 1Oxaliplatin 1Nivolumab 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Cyproheptadine 1Cyclophosphamide 1Carboplatin 1Busulfan 1Bone Marrow Transplantation 1Bone Density 1Arsenic Trioxide 1Amifostine 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatoblastoma × X-Rays × Gynecologic × Clear all
NCT04851119 2026-05-05

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Oncology Group

Phase 1/2 Recruiting
147 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡